# CABOZANTINIB
> **ANDA213878** · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABORATORIES PRIVATE LTD · Approved 2025-07-21
## Drug
- **FDA Application Number:** ANDA213878
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CABOZANTINIB
- **Generic name:** Cabozantinib
- **Active ingredients:** CABOZANTINIB
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN LABORATORIES PRIVATE LTD
- **First approval:** 2025-07-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213878)
---
*AI Analytics · CC0 1.0*